rs1990760 — IFIH1 Ala946Thr
Gain-of-function missense variant in the MDA5 viral RNA sensor, enhancing type I interferon production and increasing autoimmune disease risk
Details
- Gene
- IFIH1
- Chromosome
- 2
- Risk allele
- T
- Protein change
- p.Ala946Thr
- Consequence
- Missense
- Inheritance
- Additive
- Clinical
- Risk Factor
- Evidence
- Strong
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Immune & GutSee your personal result for IFIH1
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
IFIH1 Ala946Thr — The Viral Sensor That Can Turn Against You
Your cells contain a sophisticated alarm system for detecting viral invaders. One of the most important sensors is MDA5 (Melanoma Differentiation-Associated Gene 5)11 MDA5 (Melanoma Differentiation-Associated Gene 5)
MDA5 is encoded by the IFIH1 gene and belongs to the RIG-I-like receptor family of cytoplasmic pattern recognition receptors, a cytoplasmic helicase that detects double-stranded viral RNA and triggers the production of type I interferons — the body's primary antiviral signaling molecules. The Ala946Thr variant (rs1990760) is a C-to-T transition22 C-to-T transition
On the plus strand, the ancestral C allele encodes alanine and the derived T allele encodes threonine at position 946 in the C-terminal domain that creates a partial gain-of-function in MDA5, amplifying interferon production. This enhanced viral defense comes at a cost: elevated risk for autoimmune disease across multiple organ systems.
The T allele (946Thr) is remarkably common, carried by approximately 57% of Europeans33 57% of Europeans
Allele frequency data from gnomAD exomes shows the T allele at 0.571 globally, suggesting strong positive selection for enhanced antiviral capacity though frequencies vary substantially across populations (approximately 20% in East Asian and African populations versus 57% in Europeans). This high prevalence despite autoimmune consequences strongly suggests positive evolutionary selection44 positive evolutionary selection
The antiviral benefit of enhanced MDA5 signaling likely outweighed the autoimmune cost during historical pathogen exposure, particularly from enteroviruses driven by the survival advantage conferred against viral infections.
The Mechanism
MDA5 is a 1,025-amino acid protein that patrols the cytoplasm for signs of viral infection. When it encounters long double-stranded RNA — a hallmark of replicating viruses — it [assembles into filaments along the RNA | MDA5 binds cooperatively to dsRNA, forming helical filaments that expose its N-terminal CARD domains for downstream signaling]. These filaments activate the adaptor protein MAVS (Mitochondrial Antiviral Signaling)55 MAVS (Mitochondrial Antiviral Signaling)
MAVS sits on the outer mitochondrial membrane and relays the signal from MDA5 to transcription factors IRF3, IRF7, and NF-kB, which drive interferon-beta and pro-inflammatory cytokine production, triggering a cascade that culminates in type I interferon (IFN-alpha/beta) production.
The Ala946Thr substitution sits in the C-terminal domain (CTD)66 C-terminal domain (CTD)
The CTD regulates MDA5 nucleic acid binding and filament formation. The A946T change alters its regulatory properties, making the protein more responsive to RNA ligands of MDA5. Functional studies demonstrate that cells expressing the 946Thr variant show 2-3 fold higher basal interferon-beta mRNA77 2-3 fold higher basal interferon-beta mRNA
HEK293T cells with the risk variant showed elevated IFNB1 even without viral stimulation, and approximately 100-fold greater IFN-beta in cells accumulating endogenous dsRNA compared to the 946Ala version. The variant may increase binding affinity for RNA — including endogenous self-RNA structures that should be ignored — or resist the normal filament disassembly that shuts off signaling when it is no longer needed. The result is a sensor that runs hotter at baseline, detecting threats faster but also generating false alarms against the body's own tissues.
The Evidence
The autoimmune associations of rs1990760 are among the most replicated in human genetics. A comprehensive meta-analysis88 comprehensive meta-analysis
Cen et al. pooled data across multiple autoimmune conditions and populations established risk allele odds ratios for type 1 diabetes (OR 1.18, 95% CI 1.14-1.23), systemic lupus erythematosus (OR 1.14, 95% CI 1.07-1.22), multiple sclerosis (OR 1.18, 95% CI 1.06-1.31), and rheumatoid arthritis (OR 1.12, 95% CI 1.00-1.24). A 2023 Frontiers meta-analysis99 2023 Frontiers meta-analysis
Xiao et al. confirmed IFIH1 as an autoimmune susceptibility locus with stronger effects in Caucasian populations reinforced these findings with broader evidence.
Beyond classical autoimmune conditions, the T allele is associated with selective IgA deficiency1010 selective IgA deficiency
GWAS identified rs1990760-T with OR 1.43, p=4E-15, one of the strongest non-HLA associations for this condition (OR 1.43), psoriasis and psoriatic arthritis1111 psoriasis and psoriatic arthritis
The 946Thr variant differentiates early- vs late-onset psoriasis and increases psoriatic arthritis risk (OR 1.62) in a Spanish cohort, and [generalized vitiligo | The C allele (not T) is associated with vitiligo susceptibility; the T allele was found protective in the studied cohort].
The viral defense side of the equation is equally compelling. Knock-in mice carrying the 946Thr variant1212 Knock-in mice carrying the 946Thr variant
Gorman et al. created mice with the human A946T substitution and challenged them with lethal encephalomyocarditis virus showed dramatically improved survival against lethal viral challenge — approximately 75% of wild-type mice died while risk-variant carriers survived. These same mice, however, exhibited increased penetrance in models of streptozotocin-induced type 1 diabetes and lupus1313 streptozotocin-induced type 1 diabetes and lupus
Both autoimmune models showed more severe disease in A946T knock-in mice, confirming the variant as a genuine gain-of-function with dual consequences.
The enterovirus connection is particularly relevant for type 1 diabetes. MDA5 is the primary sensor for enteroviruses including Coxsackievirus B1414 Coxsackievirus B
CVB infection of pancreatic beta cells can trigger autoimmune destruction. The virus cleaves MDA5 via its 2A protease to evade detection, but the A946T variant may resist this cleavage more effectively, which have long been suspected as environmental triggers for T1D in genetically susceptible individuals. The 946Thr variant alters the interferon signature in Coxsackievirus-infected human pancreatic islets, potentially amplifying the inflammatory response that initiates beta-cell autoimmunity.
Practical Implications
Because the T allele is so common (the majority of most populations carry at least one copy), the per-person risk elevation is modest. Most carriers never develop autoimmune disease. However, the risk becomes clinically meaningful when combined with other autoimmune susceptibility variants or environmental triggers. If you carry TT and have a family history of type 1 diabetes, autoimmune thyroid disease, lupus, or vitiligo, your cumulative genetic risk warrants increased awareness.
The interferon-mediated mechanism provides specific intervention points. Vitamin D directly modulates type I interferon signaling through the vitamin D receptor expressed on immune cells, and omega-3 fatty acids have been shown to suppress interferon-regulated gene expression in macrophages. These targeted interventions address the specific pathway affected by this variant rather than offering general immune support.
Interactions
IFIH1 rs1990760 interacts with other autoimmune susceptibility variants in a cumulative fashion. The most notable interaction is with PTPN22 rs2476601 (R620W)1515 PTPN22 rs2476601 (R620W)
PTPN22 is the strongest non-HLA autoimmune risk variant, affecting T-cell signaling thresholds, which also increases autoimmune susceptibility through a complementary mechanism — while IFIH1 amplifies the innate immune alarm, PTPN22 lowers the threshold for adaptive immune self-reactivity. Carrying risk alleles at both loci substantially compounds autoimmune disease probability.
Within the IFIH1 gene, rs3747517 (His843Arg)1616 rs3747517 (His843Arg)
Another common IFIH1 missense variant that has been subject to positive selection and contributes independently to autoimmune risk represents a second functional variant. The haplotype combining 946Thr with 843Arg shows evidence of positive selection in African and Asian populations, likely driven by enhanced resistance to hepatitis C virus. Combined carriage of risk alleles at both IFIH1 positions and CTLA4 rs3087243 (an immune checkpoint variant) creates a multi-layered susceptibility profile spanning innate viral sensing, interferon amplification, and T-cell co-stimulation.
Genotype Interpretations
What each possible genotype means for this variant:
Normal MDA5 function with baseline interferon production and standard autoimmune risk
The CC genotype produces MDA5 with the original alanine at position 946 in the C-terminal regulatory domain. This version of the protein assembles into dsRNA-detecting filaments at normal rates and disassembles normally when the signal is no longer needed. Basal interferon-stimulated gene expression in your immune cells is at standard levels. While less common than CT or TT in most populations, this genotype carries no elevated risk for type 1 diabetes, SLE, psoriasis, vitiligo, or other MDA5-associated autoimmune conditions from this variant alone.
One gain-of-function allele modestly elevating interferon production and autoimmune susceptibility
With the CT genotype, approximately half of your MDA5 protein carries the 946Thr substitution while the other half retains the standard 946Ala. Studies of human PBMCs from heterozygous donors show intermediate levels of basal interferon-stimulated gene expression — higher than CC homozygotes but lower than TT homozygotes. The additive inheritance pattern means your autoimmune risk scales proportionally with allele dosage rather than following a dominant or recessive pattern.
For type 1 diabetes specifically, the per-allele OR of 1.18 means your heterozygous risk is modestly above baseline. Combined with the effect across multiple autoimmune conditions, this genotype warrants awareness but not alarm. The risk becomes more clinically meaningful if additional autoimmune susceptibility variants are present across the immune tolerance pathway.
Two gain-of-function alleles significantly increasing interferon production and autoimmune disease risk
Homozygous TT carriers produce MDA5 protein exclusively with the 946Thr substitution. Functional studies demonstrate that cells from TT individuals show the highest basal expression of interferon-stimulated genes — 9 of 38 measured ISGs were significantly elevated in resting PBMCs compared to CC carriers. In experimental models, TT-equivalent knock-in mice showed dramatically enhanced antiviral survival but also accelerated autoimmune disease in multiple models including streptozotocin-induced diabetes and BM12-induced lupus.
The mechanism involves both enhanced sensitivity to viral RNA and, critically, increased reactivity to endogenous self-RNA species. In ADAR1-null cells (which accumulate endogenous dsRNA), the 946Thr variant generated approximately 100-fold greater interferon-beta expression compared to 946Ala, suggesting that your MDA5 may be more prone to triggering inflammatory responses against your own RNA structures.
The autoimmune risk from TT is additive with other susceptibility variants across the immune tolerance pathway.
Key References
A946T variant mediates interferon program limiting viral infection but increasing autoimmune risk — knock-in mice and human PBMCs
Meta-analysis: T allele OR 1.18 for T1D, 1.14 for SLE, 1.18 for MS, 1.12 for RA across autoimmune diseases
2023 meta-analysis of rs1990760, rs3747517, rs10930046 confirming IFIH1 as autoimmune susceptibility locus
IFIH1 A946T regulates antiviral defence pathways in Coxsackievirus-infected human pancreatic islets
Gain-of-function IFIH1 mutations cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling
946Thr variant differentiates early- vs late-onset psoriasis and increases psoriatic arthritis risk